BALF) at day 14 we found a highly significant reduction of miR-21 (−58%) in RCS-21 treated mice compared to control mice (Fig.
← all excerpts
Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage.
1
—
—